Homeopathic Colibacillinum Drug Recall Due to Manufacturing Deviations
Washington Homeopathic Products recalls Colibacillinum homeopathic drug products due to manufacturing practice deviations. The recall involves 206 bottles distributed nationwide; the manufacturer voluntarily initiated it in May 2022.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II voluntary recall due to manufacturing practice deviations. No specific hazard is described in the source, and no illnesses or injuries have been reported, making this a precautionary manufacturing compliance recall.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Colibacillinum homeopathic liquid pellets in multiple potencies (12C, 14C, 15C, 18C, 20C, and 30C). The recall involves 206 glass amber bottles labeled with Lot # 21881 that were distributed nationwide.
The recall was initiated due to deviations from current Good Manufacturing Practice (cGMP) requirements. The manufacturer voluntarily initiated the recall on May 13, 2022, and the FDA classified it as a Class II recall.
Consumers who have this product should stop using it and consider returning it to the place of purchase. The recall was terminated on May 25, 2023.
The recalled product
- Product
- Colibacillinum, Potency: 12C, 14C, 15C, 18C, 20C, 30C, Liquid Pellets, OTC, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — OTC Homeopathic
- Hazard
- Affected units
- 206
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot # 21881
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 17 recalled by Washington Homeopathic Products, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 17 products in this recall →Related recalls
Same manufacturer · Washington Homeopathic Products, Inc.
See all →- LowHomeopathic Kit Recalled for Label Mix-up Between Products
FDA (Drugs) · 2024-07-31
- ModerateHomeopathic Tuberculinum Drug Recalled for Manufacturing Practice Deviations
FDA (Drugs) · 2022-06-22
- ModerateDrug recall: Tuberculinum Bovinum due to manufacturing practice deviations
FDA (Drugs) · 2022-06-22
- ModeratePyrogenium Homeopathic Remedy Recalled for Manufacturing Process Violations
FDA (Drugs) · 2022-06-22
- ModerateHomeopathic Drug Anthracinum Recalled Over Manufacturing Compliance Deviations
FDA (Drugs) · 2022-06-22
Same hazard · gmp deviation
See all →- HighPrazosin hydrochloride tablets recalled over nitrosamine impurity above limits
FDA (Drugs) · 2026-04-08
- HighPrazosin hydrochloride further lots recalled over nitrosamine impurity levels
FDA (Drugs) · 2026-04-08
- HighPrazosin hydrochloride 100-count bottles recalled over nitrosamine impurity
FDA (Drugs) · 2026-04-08
- ModerateFirst Aid Only hand sanitizing wipes recalled over manufacturing deviations
FDA (Drugs) · 2026-03-11
- ModerateFirst Aid Only BZK antiseptic towelettes recalled over manufacturing deviations
FDA (Drugs) · 2026-03-11
Similar recalls
- ModerateWashington Homeopathic Products Recalls Kali Muriaticum 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- HighWashington Homeopathic Products Recalls Silicea 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- ModerateWashington Homeopathic Recalls Natrum Muriaticum 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- ModerateWashington Homeopathic Recalls Natrum Sulphuricum 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- ModerateWashington Homeopathic Products Recalls Kali Sulphuricum 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- ModerateWashington Homeopathic Products Recalls Kali Phosphoricum 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27